NCT03431688View on ClinicalTrials.gov

Tailored Therapy for Clarithromycin-Resistant H. Pylori

NACompletedINTERVENTIONAL
Enrollment

782

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

October 30, 2020

Study Completion Date

December 30, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

PAM

treatment with PPI, metonidazole, amoxicillin

DRUG

PBMT

treatment with PPI, metonidazole, bismuth, tetracyclin

Trial Locations (1)

134-701

Kangdong Sacred Heart Hospital, Seoul

All Listed Sponsors
lead

Kangdong Sacred Heart Hospital

OTHER

NCT03431688 - Tailored Therapy for Clarithromycin-Resistant H. Pylori | Biotech Hunter | Biotech Hunter